SELENON Related Myopathy (Aka SEPN1)

Explore clinical trials studying SELENON Related Myopathy (Aka SEPN1). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

SELENON Related Myopathy (Aka SEPN1) trial results

Recruiting

NCT01403402

Conditions: Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Fatty Liver and Infantile-onset Cataract Caused by TRAPPC11 Mutations), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan and Epilepsy), Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy With Hypoglycosylation of Dystroglycan), +89 more
Locations: Congenital Muscle Disease International Registry (www.cmdir.org) Lakewood, California, United States